LIFE-ME: Lifecare Engages Top International Nanotechnology Expert to serve as Scientific Advisor for the Sencell Development!

Lifecare Engages Top International Nanotechnology Expert to serve as Scientific
Advisor for the Sencell Development!
 
Lifecare AS is pleased to welcome Prof. Michael Huth, Professor for Thinlayer
Physics at the Johann-Wolfgang-vom-Goethe University in Frankfurt and one of the
Global International Leaders in the field of Nanosensing Technology as a new
member of the Scientific Advisory Board for the Sencell Development.
 
"Prof. Huth is an outstanding scientist and will bring extremely valuable
support to the existing advisory board, which is already composed of leading
international experts in the field of diabetes and diabetes technology" says
Prof. Andreas Pfützner,  Chief Scientific Officer of Lifecare and Christian Torp
Saure, Lifecare's Executive Chairman, adds: "Having Prof. Huth join our advisory
board is not only a major achievement in the atempt to finalize the Sencell
development, but also a further proof for the acceptance by the scientific
community of Lifecare's Sencell development and for the companies' vision to
help people suffering from diabetes."     
 
In addition to Prof Huth the Lifecare AS' Scientific Advisory Board includes:

Chairman: 	Prof. David C. Klonoff
-	Clinical Professor of Medicine, University of California San Francisco
-	Medical Director of the Dorothy L. and James E. Frank Diabetes Research       
                    
        Institute of Mills-Peninsula Medical Center
-	Editor in Chief, Journal of Diabetes Science and Technology
-	Chairman, Diabetes Technology Meeting

Member:	        Prof. Lutz Heinemann
-	Founding Partner, Profil Institute for Metabolic Research in Neuss, Germany
-	Member of the German Diabetes Association (DDG), the European Association     
                          
        for the Study of Diabetes (EASD)and the American Diabetes Association
(ADA)
-	Co-Editor, Journal of Diabetes Science and Technology
-	Awarded for “Leadership in Diabetes Technology” and “Artificial Pancreas      
                     
        Research Award” from the Diabetes Technology Society

Member / CMO:   Prof. Kåre Birkeland
-	Professor of Internal Medicine and Endocrinology, University of Oslo
-	Senior consultant in Endocrinology, Dep. of Transplantation Medicine,         
              
        Rikshospitalet, Oslo University Hospital
-	Chairman Advisory Board, Norwegian Diabetes Association

About Lifecare
Lifecare is a Norwegian life-science company, headquartered in Bergen. The
Company was incorporated on 4 September 2006. Lifecare is developing an
implantable continuous monitoring device and technology, Sencell Glucose Sensor,
for glucose assessment. Lifecare has the intellectual property rights to the
underlying nanotechnology and MEMS-technology to realize the product
development. Lifecare recently entered a Joint Venture with IMS Capital Partners
GmbH founding Digital Diagnostics AG to finalize the Sencell development. 



For more information or interviews, please contact:
Christian Torp Saure
Chairman, Lifecare
+ 47 90933148
christian@sternacap.no